As of October 2026 Retension Pharmaceuticals has a market cap of โฌ0.12 Billion. This makes Retension Pharmaceuticals the world's 9471th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.